DYAI
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
30.03M
38 days until earnings call
NAUT
Price
$0.69
Change
-$0.10 (-12.66%)
Updated
Jun 27 closing price
Capitalization
87.51M
36 days until earnings call
Interact to see
Advertisement

DYAI vs NAUT

Header iconDYAI vs NAUT Comparison
Open Charts DYAI vs NAUTBanner chart's image
Dyadic International
Price$1.00
Change-$0.00 (-0.00%)
Volume$126.27K
Capitalization30.03M
Nautilus Biotechnolgy
Price$0.69
Change-$0.10 (-12.66%)
Volume$5.73M
Capitalization87.51M
DYAI vs NAUT Comparison Chart in %
Loading...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYAI vs. NAUT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYAI is a Buy and NAUT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DYAI: $1.00 vs. NAUT: $0.69)
Brand notoriety: DYAI and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYAI: 300% vs. NAUT: 1671%
Market capitalization -- DYAI: $30.06M vs. NAUT: $87.51M
DYAI [@Biotechnology] is valued at $30.06M. NAUT’s [@Biotechnology] market capitalization is $87.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYAI’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • DYAI’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, NAUT is a better buy in the long-term than DYAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYAI’s TA Score shows that 6 TA indicator(s) are bullish while NAUT’s TA Score has 3 bullish TA indicator(s).

  • DYAI’s TA Score: 6 bullish, 2 bearish.
  • NAUT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DYAI is a better buy in the short-term than NAUT.

Price Growth

DYAI (@Biotechnology) experienced а +9.53% price change this week, while NAUT (@Biotechnology) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DYAI is expected to report earnings on Aug 06, 2025.

NAUT is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAUT($87.5M) has a higher market cap than DYAI($30M). DYAI YTD gains are higher at: -42.920 vs. NAUT (-58.708). DYAI has higher annual earnings (EBITDA): -5.32M vs. NAUT (-72.33M). NAUT has more cash in the bank: 139M vs. DYAI (7.35M). DYAI has less debt than NAUT: DYAI (5.07M) vs NAUT (29.3M). DYAI has higher revenues than NAUT: DYAI (3.34M) vs NAUT (0).
DYAINAUTDYAI / NAUT
Capitalization30M87.5M34%
EBITDA-5.32M-72.33M7%
Gain YTD-42.920-58.70873%
P/E RatioN/AN/A-
Revenue3.34M0-
Total Cash7.35M139M5%
Total Debt5.07M29.3M17%
FUNDAMENTALS RATINGS
DYAI vs NAUT: Fundamental Ratings
DYAI
NAUT
OUTLOOK RATING
1..100
213
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
8791
P/E GROWTH RATING
1..100
69100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (11) in the null industry is significantly better than the same rating for DYAI (94) in the Biotechnology industry. This means that NAUT’s stock grew significantly faster than DYAI’s over the last 12 months.

NAUT's Profit vs Risk Rating (100) in the null industry is in the same range as DYAI (100) in the Biotechnology industry. This means that NAUT’s stock grew similarly to DYAI’s over the last 12 months.

NAUT's SMR Rating (96) in the null industry is in the same range as DYAI (99) in the Biotechnology industry. This means that NAUT’s stock grew similarly to DYAI’s over the last 12 months.

DYAI's Price Growth Rating (87) in the Biotechnology industry is in the same range as NAUT (91) in the null industry. This means that DYAI’s stock grew similarly to NAUT’s over the last 12 months.

DYAI's P/E Growth Rating (69) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that DYAI’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYAINAUT
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 17 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLDBF1.540.01
+0.63%
WILDBRAIN LTD.
KAJMY25.04N/A
N/A
Kajima Corp.
SBFFY26.98N/A
N/A
SBM Offshore NV
MAYX5.55N/A
N/A
Mayex USA, Inc.
FLWBF0.05N/A
N/A
Flow Beverage Corp.

DYAI and

Correlation & Price change

A.I.dvisor tells us that DYAI and CGTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and CGTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
+0.39%
CGTX - DYAI
29%
Poorly correlated
N/A
VYNE - DYAI
24%
Poorly correlated
-12.35%
NAUT - DYAI
23%
Poorly correlated
-12.57%
LEGN - DYAI
23%
Poorly correlated
+3.43%
LRMR - DYAI
23%
Poorly correlated
N/A
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-12.57%
FHTX - NAUT
47%
Loosely correlated
-0.41%
IMNM - NAUT
45%
Loosely correlated
-0.23%
TECH - NAUT
43%
Loosely correlated
-1.82%
RXRX - NAUT
42%
Loosely correlated
-6.85%
PROK - NAUT
42%
Loosely correlated
-7.50%
More